Abstract:Background Probiotics have been shown to improve neurocognitive behaviour in animal models via the gut-brain-axis. This meta-analysis aims to evaluate the evidence in human studies on the potential of probiotics as a treatment for age-related neurodegeneration such as Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD). Methods A PRISMA meta-analysis was conducted by screening through MEDLINE, Embase, Scopus, Web of Science and Cochrane library for human studies using equivalent combinations of ‘probiotics’, ‘age-related neurodegeneration’, ‘MCI’ and ‘AD’. Studies with Mini-mental State Examination (MMSE), a test for cognitive function with comparable quantitative outcome were meta-analysed using RStudio. The analysis for overall effect (95% CI) and heterogeneity (I2) was performed by Forest Plots and subgroup analysis. We further assessed whether the results varied with age,%female, BMI, dosage and sample size with weighted meta-regression. Probiotic amelioration of neurodegeneration was also evaluated through biomarker analysis. Results 9 human studies were identified, where 5 studies had quantitative results. Meta-analysis demonstrates that there is a 0.9 mark (0.1 to 1.9) improvement in MMSE scores in human RCTs, though the results are quite heterogeneous (I2 = 94%) (figure 1). Subgroup analysis of MCI and AD models were divergent with a difference of -0.1 (-0.3 to 0.2) versus a 1.7 (0.9 to 2.5) difference in MMSE score between the two groups. Studies also report improvement in other cognitive tests, such as CERAD and RBANS. Meta-regression revealed that the improvement in MMSE scores is age-dependent (p < 0.005) in humans. Biomarker analysis suggests that probiotic supplementation upregulates anti-oxidative (↓MDA) and anti-inflammatory (↓hs-CRP) pathways. Studies also show an improvement in non-neurological symptoms such as in insulin sensitivity (↓HOMA-IR, ↑QUICKI), and lipid profiles (↓TG, VLDL). However, an intervention study reported an increase in kynurenine:tryptophan ratio post probiotic supplementation, suggesting an activation of inflammatory pathways. Conclusions Human study evidence generally shows an association between probiotic supplementation and improved neurocognitive function, although confounded by age and severity of neurodegeneration. Caution should be applied in the use of probiotics as an intervention for cognitive decline.

Psychobiotics for Mitigation of Neuro-Degenerative Diseases: Recent Advancements

Unveiling the Therapeutic Potential of Modern Probiotics in Addressing Neurodegenerative Disorders: A Comprehensive Exploration, Review and Future Perspectives on Intervention Strategies

The Effect of Probiotic Intervention in Ameliorating the Altered Central Nervous System Functions in Neurological Disorders: A Review

Postbiotics as Molecules Targeting Cellular Events of Aging Brain—The Role in Pathogenesis, Prophylaxis and Treatment of Neurodegenerative Diseases

A review of the preclinical and clinical studies on the role of the gut microbiome in aging and neurodegenerative diseases and its modulation

Probiotics for Neurodegenerative Diseases: A Systemic Review

Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis

Ageing, proteostasis, and the gut: Insights into neurological health and disease

Probiotics and Paraprobiotics: Effects on Microbiota-Gut-Brain Axis and Their Consequent Potential in Neuropsychiatric Therapy

Gut brain regulation using psychobiotics for improved neuropsychological illness

Probiotic Supplementation Demonstrates Therapeutic Potential in Treating Gut Dysbiosis and Improving Neurocognitive Function in Age-Related Dementia

Role of Probiotics and Diet in the Management of Neurological Diseases and Mood States: A Review

A comprehensive review on the pharmacological role of gut microbiome in neurodegenerative disorders: potential therapeutic targets

Psychobiotic Properties of Lactiplantibacillus plantarum in Neurodegenerative Diseases

Opening avenues for treatment of neurodegenerative disease using post-biotics: Breakthroughs and bottlenecks in clinical translation

Using Synbiotics as a Therapy to Protect Mental Health in Alzheimer's Disease

Unveiling the Interplay of AMPK/SIRT1/PGC-1α axis in Brain Health: Promising Targets Against Aging and NDDs

IDDF2020-ABS-0202 Meta-analysis on the Effect of Probiotics on Neurodegenerative Disorders in Humans Clinical Trials

Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights

Nutritional strategies modulating the gut microbiome as a preventative and therapeutic approach in normal and pathological age-related cognitive decline: a systematic review of preclinical and clinical findings

Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders